We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$51B
AUM Growth
+$4.88B
Cap. Flow
+$834M
Cap. Flow %
1.63%
Top 10 Hldgs %
25.68%
Holding
986
New
26
Increased
432
Reduced
416
Closed
39

Top Buys

Rank Stock Value
1
KSPI icon
Kaspi.kz JSC
KSPI
+$260M
2
MSFT icon
Microsoft
MSFT
+$71.2M
3
CAH icon
Cardinal Health
CAH
+$61.4M
4
CLX icon
Clorox
CLX
+$47.7M
5
ACN icon
Accenture
ACN
+$46.1M

Sector Composition

Rank Sector Weight
1 Technology 28.39%
2 Healthcare 17.34%
3 Financials 11.02%
4 Consumer Discretionary 9.2%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REXR icon
776
Rexford Industrial Realty
REXR
$8.46B
$1.93M ﹤0.01%
38,371
-1,854
-5% -$98.1K
LU icon
777
Lufax Holding
LU
$1.2B
$1.93M ﹤0.01%
456,512
+208,624
+84% +$584K
DQ
778
Daqo New Energy
DQ
$821M
$1.92M ﹤0.01%
68,225
+47,954
+237% +$1.07M
IBN icon
779
ICICI Bank
IBN
$107B
$1.91M ﹤0.01%
+72,395
New +$1.81M
CCK icon
780
Crown Holdings
CCK
$13.1B
$1.9M ﹤0.01%
24,012
-525,664
-96% -$43M
QFIN icon
781
Qfin Holdings
QFIN
$1.55B
$1.88M ﹤0.01%
101,978
+19,895
+24% +$312K
AMCR icon
782
Amcor
AMCR
$20.3B
$1.87M ﹤0.01%
39,299
+6,426
+20% +$301K
CUBE icon
783
CubeSmart
CUBE
$9.48B
$1.85M ﹤0.01%
40,980
-1,940
-5% -$86K
GTHX
784
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.83M ﹤0.01%
423,869
VRNS icon
785
Varonis Systems
VRNS
$5.46B
$1.82M ﹤0.01%
38,484
-1,864
-5% -$88.8K
GSK icon
786
GSK
GSK
$104B
$1.79M ﹤0.01%
41,852
BXSL icon
787
Blackstone Secured Lending
BXSL
$5.54B
$1.79M ﹤0.01%
57,497
PCTY icon
788
Paylocity
PCTY
$6.75B
$1.79M ﹤0.01%
10,401
-104,890
-91% -$17.3M
HYG icon
789
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$1.72M ﹤0.01%
22,135
+14,674
+197% +$1.13M
WLK icon
790
Westlake Corp
WLK
$9.95B
$1.68M ﹤0.01%
10,984
-239
-2% -$33.6K
TCOM icon
791
Trip.com Group
TCOM
$26.7B
$1.64M ﹤0.01%
37,267
-3,670
-9% -$149K
DY icon
792
Dycom Industries
DY
$12.2B
$1.59M ﹤0.01%
11,100
-300
-3% -$37K
TCRX icon
793
TScan Therapeutics
TCRX
$59.8M
$1.59M ﹤0.01%
200,000
KRNT icon
794
Kornit Digital
KRNT
$696M
$1.58M ﹤0.01%
87,126
+19,763
+29% +$346K
FOX icon
795
Fox Class B
FOX
$21.7B
$1.57M ﹤0.01%
54,829
-1,308
-2% -$36.6K
LSXMK
796
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$1.54M ﹤0.01%
51,842
-1,123
-2% -$33.7K
XRN
797
Chiron Real Estate Inc
XRN
$549M
$1.53M ﹤0.01%
34,979
AAL icon
798
American Airlines Group
AAL
$9.91B
$1.51M ﹤0.01%
98,587
-4,593
-4% -$66.6K
EGP icon
799
EastGroup Properties
EGP
$11.9B
$1.5M ﹤0.01%
8,349
-405
-5% -$73K
GMAB icon
800
Genmab
GMAB
$17.6B
$1.49M ﹤0.01%
+49,797
New +$1.46M

Similar funds

Aberdeen Group's Q1 2024 Portfolio in Review

As of Q1 2024, Aberdeen Group held 986 positions worth $51B, up 11% from $46.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Aberdeen Group's Q1 2024 filing shows 26 new, 432 increased, 416 reduced and 39 closed positions. Its largest new stake was Kaspi.kz JSC: 2,541,596 shares worth $327M. The largest sale was Sociedad Química y Minera de Chile, an estimated $63.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • Aberdeen Group's largest Q1 2024 buy was Kaspi.kz JSC: 2,541,596 shares worth $327M.
  • Aberdeen Group added most to Microsoft in Q1 2024, an estimated $71.2M increase.
  • Aberdeen Group's biggest Q1 2024 reduction was Sociedad Química y Minera de Chile, cutting an estimated $63.6M.
  • Aberdeen Group fully exited Splunk Inc in Q1 2024, selling an estimated $56.2M.
  • Aberdeen Group's ten largest holdings make up 26% of its $51B portfolio in Q1 2024.
  • Aberdeen Group opened 26 new positions and closed 39 in Q1 2024.
  • Aberdeen Group's portfolio value rose 11% quarter-over-quarter to $51B.

Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.